AYTU · Aytu BioPharma Inc
United States · RS rating 23 · As of 2026-10-14
| Price | 1.95 USD |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 52 / 32 / 28 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 15 / 15 / 3 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -1212.5% |
| Sales growth Q/Q | +9.2% |
| Distance from 52-week high | +32.8% |
| Market cap (USD) | $27.0M |